cervical cancer	is a	malignant neoplasm
cervical cancer	arises from	cervical epithelium
HPV infection	is a risk factor for	cervical cancer
HPV infection	is associated with	cervical cancer
smoking	increases risk of	cervical cancer
multiple sexual partners	increases risk of	cervical cancer
early sexual activity	increases risk of	cervical cancer
HIV infection	increases risk of	cervical cancer
immunosuppression	increases risk of	cervical cancer
parity	increases risk of	cervical cancer
long-term oral contraceptives	increases risk of	cervical cancer
HPV vaccination	reduces risk of	cervical cancer
Pap smear	screens for	cervical cancer precursors
HPV DNA testing	detects	high-risk HPV infection
colposcopy	used for	evaluation of cervical abnormalities
biopsy	confirms	cervical cancer
MRI	used for	staging of cervical cancer
CT scan	used for	assessment of metastasis
PET-CT	detects	metastatic disease in cervical cancer
FIGO stage	classifies	cervical cancer
stage I cervical cancer	has	favorable prognosis
stage IV cervical cancer	has	poor prognosis
tumor size	affects	prognosis
lymph node involvement	worsens	prognosis
squamous cell carcinoma	is a histology type of	cervical cancer
adenocarcinoma	is a histology type of	cervical cancer
microinvasion	defines	early cervical cancer
cone biopsy	used for	diagnostic excision of CIN
surgery	used for	early cervical cancer
radical hysterectomy	used for	early-stage cervical cancer
trachelectomy	used for	fertility preservation
brachytherapy	used for	local control of cervical cancer
external beam radiotherapy	used for	locally advanced cervical cancer
concurrent chemoradiation	standard of care for	locally advanced cervical cancer
cisplatin-based chemotherapy	used with	radiotherapy
bevacizumab	added to	chemotherapy for cervical cancer
immunotherapy	studied in	cervical cancer
pembrolizumab	studied in	cervical cancer
neoadjuvant chemotherapy	given before	surgery for cervical cancer
adjuvant radiotherapy	given after	surgery for cervical cancer
lymphadenectomy	performed for	nodal staging
hysterectomy	removes	uterus
pelvic lymphadenectomy	provides	nodal staging
p16 expression	used as	biomarker for HPV-driven cancer
Ki-67 expression	indicates	tumor proliferation
HPV vaccination program	reduces incidence of	cervical cancer
abnormal Pap smear	prompts	colposcopy
colposcopic biopsy	yields	cervical tissue sample
biopsy sample	confirms	cervical cancer
MRI pelvis	assesses	tumor extent
CT abdomen pelvis	detects	lymph node metastasis
pathologic stage	guides	treatment planning
lymph node metastasis	worsens	prognosis
lung metastasis	indicates	advanced disease
hepatic metastasis	indicates	advanced disease
bone metastasis	indicates	advanced disease
radiation therapy	improves	local control
surgery	aims for	disease-free survival
adjuvant therapy	improves	recurrence-free survival
recurrence	indicates	treatment failure
fertility preservation	enabled by	radical trachelectomy
pregnancy after treatment	possible for	select survivors
sexual function	affected by	pelvic radiotherapy
ovarian function	affected by	pelvic radiotherapy
tumor differentiation	affects	treatment choice
tumor grade	influences	treatment approach
pathologic stage	determines	prognosis
staging	relies on	imaging studies
HPV16 infection	associated with	high-risk HPV-related cervical cancer
HPV18 infection	associated with	high-risk HPV-related cervical cancer
p16 overexpression	predicts	HPV-driven cervical cancer
recurrence risk	correlates with	surgical margins
surgical margins	predict	recurrence
lymphovascular invasion	indicates	aggressive disease
depth of stromal invasion	correlates with	prognosis
tumor grade	correlates with	prognosis
radiation dose	varies with	stage
fertility-sparing strategies	require	careful patient selection
HPV types 16 and 18	are common	high-risk HPV types
early detection	improves	survival
screening interval	varies by	age group
age group	determines	screening interval
vaccination uptake	correlates with	cervical cancer incidence
regional variation	affects	screening coverage
screening coverage	affects	early detection rate
recurrence risk	depends on	residual disease
survivorship	includes	long-term follow-up
surveillance imaging	monitors	recurrence
cervical cancer	is prevalent in	developing countries
cervical cancer	is more common in	women aged 35-44
risk factors	include	HPV infection
cervical cancer	is preventable by	HPV vaccination
cervical cancer	requires	multidisciplinary care
staging	guides	treatment type
fertility preservation	possible with	early-stage cervical cancer
ovarian suppression	used for	hormone-responsive tumors (cervical cancer context)
positive margins	predict	recurrence
margins status	influences	adjuvant therapy decision
tumor invasion	extends to	parametrium
parametrium invasion	defines	stage IIb
stage IIb	upstages	disease
overall survival	measures	patient survival
disease-free survival	measures	treatment success
early detection	enables	cure likelihood
